“Tom Abate’s reporting on biotechnology has always been ahead of the times. The Biotech Investor tackles the brave new world of stem cells, genomics, and clones and comes up a winner.” —Thom Calandra, editor in chief, CBS MarketWatch

In The Biotech Investor, San Francisco Chronicle biotechnology reporter Tom Abate explains the science, finances, time horizon, and technological and commercial potential of this burgeoning industry. Abate provides guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He shares strategies for • tracking the effect of breaking news and the NASDAQ • anticipating drug trial announcements and FDA approvals • assessing the potential market, patent rights, and distribution deals for a drug He looks beyond medicine to biotech-related opportunities in everything from agriculture to jean manufacturing to software development. The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century’s most promising industries.

About the Author&colon;

One of the nation’s most influential observers of the biotechnology industry, award-winning technology and health-care reporter Tom Abate writes the weekly “BioScope” column for the San Francisco Chronicle. He lives in San Leandro, California.

"About this title" may belong to another edition of this title.

Customers Who Bought This Item Also Bought:

The Biotech Investor: How to Profit from the Coming Boom in Biotechnology: Search Results

Book Description:SMITHSONIAN INST PR 01/10/2014, 2014. Paperback. Book Condition: New. New Book. This item is printed on demand. Shipped from US This item is printed on demand. Bookseller Inventory # IH-9780805075083

Book Description:Henry Holt Company Inc, United States, 2004. Paperback. Book Condition: New. Reprint. 213 x 137 mm. Language: English Brand New Book ***** Print on Demand *****. Tom Abate s reporting on biotechnology has always been ahead of the times. The Biotech Investor tackles the brave new world of stem cells, genomics, and clones and comes up a winner. --Thom Calandra, editor in chief, CBS MarketWatch In The Biotech Investor, San Francisco Chronicle biotechnology reporter Tom Abate explains the science, finances, time horizon, and technological and commercial potential of this burgeoning industry. Abate provides guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He shares strategies for- tracking the effect of breaking news and the NASDAQ- anticipating drug trial announcements and FDA approvals- assessing the potential market, patent rights, and distribution deals for a drugHe looks beyond medicine to biotech-related opportunities in everything from agriculture to jean manufacturing to software development. The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century s most promising industries. Bookseller Inventory # APC9780805075083

Book Description:Henry Holt Company Inc, United States, 2004. Paperback. Book Condition: New. Reprint. 213 x 137 mm. Language: English Brand New Book ***** Print on Demand *****. Tom Abate s reporting on biotechnology has always been ahead of the times. The Biotech Investor tackles the brave new world of stem cells, genomics, and clones and comes up a winner. --Thom Calandra, editor in chief, CBS MarketWatch In The Biotech Investor, San Francisco Chronicle biotechnology reporter Tom Abate explains the science, finances, time horizon, and technological and commercial potential of this burgeoning industry. Abate provides guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He shares strategies for- tracking the effect of breaking news and the NASDAQ- anticipating drug trial announcements and FDA approvals- assessing the potential market, patent rights, and distribution deals for a drugHe looks beyond medicine to biotech-related opportunities in everything from agriculture to jean manufacturing to software development. The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century s most promising industries. Bookseller Inventory # APC9780805075083